as a critical calciotropic hormone is well established, as it plays a pivotal role in plasma calcium homeostasis and skeletal mineral balance. It is now recognized that vitamin D has other functions and may play a role in immunity and cell differentiation (1) (2) (3) . Recent animal and human studies have suggested that vitamin D deficiency may be an etiologic factor in the pathogenesis of autoimmune diseases such as Graves disease (4 ), multiple sclerosis (5 ), juvenile idiopathic arthritis (6 ) , and type 1 diabetes mellitus (7 ) . In view of the growing awareness of the roles of vitamin D, accurate assessment of vitamin D status has become increasingly important. However, assessment of vitamin D status is relatively unreliable because it depends on measuring total circulating 25-hydroxyvitamin D 3 (25OHD 3 ) concentrations rather than determining the concentration of the free, biologically active component.
25OHD 3 and 1,25(OH) 2 D 3 are hydrophobic molecules with low plasma solubility and are therefore transported in the circulation bound to plasma proteins. A very large proportion of circulating 25OHD 3 and 1,25(OH) 2 D 3 is bound to vitamin D-binding protein (DBP) and albumin, and only 0.02%-0.05% of 25OHD 3 and 0.2%-0.6% of total 1,25(OH) 2 D 3 remain free or unbound (8 ) . DBP has greater affinity for 25OHD 3 than for 1,25(OH) 2 D 3 ; the dissociation constants for the 2 metabolites differ by 10-fold (8 ) . In mammals, DBP exhibits the same relative affinities for vitamin D 2 and D 3 metabolites. DBP (also known as Gc globulin, or Gc) is a 52-to 58-kDa glycoprotein that is synthesized in the liver. DBP circulates in plasma at concentrations 20-fold higher than the total amount of vitamin D metabolites (9 ) . 25OHD 3 and 24,25-dihydroxyvitamin D circulate in blood at concentrations ϳ1000-fold higher than those of 1,25(OH) 2 D 3 ; however, because the molar concentration of the circulating DBP in relation to all of the vitamin D metabolites is 20-fold higher, many DBP binding sites remain unoccupied. These unoccupied DBP sites bind most of the circulating 1,25(OH) 2 D 3 , and consequently, the percentage concentration of free hormone is very low. The physiologic consequence of the large molar excess of circulating DBP, which differs from other steroid hormone carrier proteins, is unclear. DBP has a single sterol binding site, and only 5% of the total DBP is usually occupied with vitamin D compounds. Therefore, under physiologic conditions, nearly all circulating vitamin D compounds are protein bound, which has a great influence on vitamin D pharmacokinetics. Protein-bound vitamin D metabolites will have limited access to target cells (10 ) and are likely to be biologically inactive. An implication of this observation is that the concentrations of the free rather than total forms of 1,25(OH) 2 D 3 and 25OHD 3 are likely to provide better assessment of functional vitamin D status. Because malabsorption of calcium has previously been reported in men with osteoporosis (11 ), we compared calculated free and total 25OHD 3 and 1,25(OH) 2 D 3 in men with idiopathic osteoporosis and male controls.
Materials and Methods participants
The study population comprised 56 men with idiopathic osteoporosis [mean (SD) age, 59.6 (13.6) years; range, 21-86 years] attending the Bone Clinic, Freeman Hospital, Newcastle Upon Tyne (United Kingdom) and 114 male controls [62.4 (10.4) years; range, 44 -82 years] from Derby (United Kingdom). All participants in the study were Caucasian and were from 2 industrial cities in Northern England. The osteoporotic men all had a bone mineral density (BMD) t-score below Ϫ2.5 at either the femoral neck or lumbar spine. Of the osteoporotic men, 45 had a history of fractures (33 symptomatic vertebral, 6 hip, 2 forearm, and 4 other fractures) and 11 had no previous fractures. The fractures had all occurred at least 6 months before inclusion of the men in the study, and all blood samples were taken before the initiation of therapy. Underlying secondary causes of osteoporosis were excluded by medical history, physical examination, and laboratory investigation, which led to the exclusion of 66 men with osteoporosis. The laboratory investigation included full blood counts, erythrocyte sedimentation rates, biochemical profiles, thyroid function tests, and measurement of serum testosterone, sex hormone-binding globulin (SHBG), and gonadotropins (12 ) . Previous work showed that 54% of men attending the Bone Clinic in Newcastle with vertebral fractures have an underlying secondary cause of osteoporosis (13 ) .
The 114 male controls were a subset of the 198 men without low-trauma fractures who had previously taken part in a case-control study of distal forearm fractures (14 ) and subsequently agreed to have blood tests. Men were recruited from a preexisting database in Derby of 692 male controls and had all attended clinic for bone densitometry determinations in 1998. They had been recruited from the city of Derby and its environs via notices in general practitioners' offices and in local newspapers. The study was approved by the local ethics committee, and informed written consent was obtained from all participants.
biochemical and bmd measurements
Possible differences attributable to the diurnal variation in vitamin D status were minimized by ensuring that all venesections were performed in the morning. Differences attributable to seasonal variation in vitamin D status were minimized by undertaking venesection throughout the year in both groups, so that the number of samples collected through the seasons were balanced. The following analyses were performed on serum, on an Olympus AU640: creatinine (inter-and intraassay CVs, 0.7%-1.0% and 2.2%-2.3%) and alkaline phosphatase (0.6%-3.5% and 2.1%-4.6%). All laboratory tests were subject to validation by use of National External Quality Assurance Schemes. Glomerular filtration rate was estimated from serum creatinine, body weight, and age by use of the CockcroftGault formula.
All bone density measurements were performed by dual x-ray absorptiometry performed on a QDR 2000 (Hologic). In vivo imprecision for measurement with this system is 1.0% at the lumbar spine (L1-L4) and 1.5% for the femoral neck. BMD results were obtained as the areal density in g/cm 2 , but are also given as t-and z-scores. The t-score is the number of SD above or below the mean for healthy young men, whereas the z-score is the number of SD above or below the age-related normal mean (calculated by use of the manufacturer's standard reference database).
ria for measurement of dbp
The total plasma DBP was determined by use of monospecific polyclonal goat anti-human DBP antibodies (Diasorin) in a competitive RIA (15 ) . Briefly, microtiter plates were coated with the anti-human Gc-globulin antibody in triplicate and incubated overnight at 4°C. The microtiter plates were then washed 6 times with phosphate buffer containing Tween.
125 I-labeled DBP was added in fixed amounts (100 L containing 80 000 cpm) and allowed to bind for 48 h. After incubation, the microtiter wells were again washed 6 times with phosphate buffer containing Tween and slapped dry; the radioactivity in the wells was then measured with a gamma counter (Packard Cobra). The intraassay CV, determined using 24 replicates of samples, was between 4.3% and 5.4%, and the interassay CV was 5.3%-7.8%. assay for 25ohd 3 The assay used was a liquid-phase RIA for the quantitative determination of 25OHD 3 in human plasma (Immunodiagnostics Ltd.). Briefly, plasma 25OHD 3 was extracted according to the manufacturer's instructions, and portions of the supernatant were incubated with 125 Ilabeled 25OHD 3 tracer and sheep anti-25OHD 3 polyclonal antibody for 90 min. Separation of the antibody-bound tracer from free analyte was achieved by a short incubation with Sac-Cel ® (solid phase anti-sheep IgG cellulose). The intra-and interassay CVs of the method are 5.3%-6.1%, and 7.3%-8.2%, respectively. assay for 1,25(oh) 2 
d 3
The assay for plasma 1,25(OH) 2 D 3 was performed with commercially available reagents (Gamma-B reagent set; Immunodiagnostic Ltd.). Immunoextraction was carried out with an anti-1,25(OH) 2 D 3 monoclonal antibody attached to a solid phase. Primary antibody was added to tubes containing calibrators and to the tubes containing the extracts, which were then incubated overnight at 4°C. The following day, tracer was added and incubated at 25°C for 2 h, after which Sac Cel solid-phase second antibody was added. After 30 min, wash solution was added to dilute the assay mixture, and the tubes were subjected to centrifugation. The liquid was decanted, the tubes were allowed to drain. and the 125 I activity remaining in the pellets was counted. The intra-and interassay CVs of the method were 9.1%-11% and 9.6%-14%, respectively.
calculated free vitamin d metabolites
The free plasma 25OHD 3 and 1,25(OH) 2 D 3 concentrations were calculated by use of the following equations:
where [T] and [F] are the total and free vitamin concentrations, respectively, and K a ALB and K a DBP are the association constants for 25OHD 3 and 1,25(OH) 2 D 3 with albumin (ALB) and DBP. Most plasma 25OHD 3 is bound to circulating DBP (85%-90%); however, plasma DBP concentrations show considerable individual variability. The remainder of plasma 25OHD 3 is bound mainly to plasma albumin, which in our study can be ignored because this smaller fraction is almost constant. The plasma albumin concentrations in the male controls and men with osteoporosis were quite similar and within the reference interval. The affinity constant of albumin (K a ALB ) for 25OHD 3 is much lower (6 ϫ 10 5 L/mol) than the affinity constant of DBP (K a DBP ) for 25OHD 3 (0.6 ϫ 10 9 L/mol) (8, 16, 17 (8, 16 -18 ) .
data analysis
Results are presented as the mean (SD). Data were analyzed by appropriate statistical packages (Microsoft Excel XL). We used the Mann-Whitney test to determine significant differences in BMD, anthropometric measurements, DBP, and vitamin D metabolites between osteoporotic men and male controls.
Results
The ages and results of anthropometric and BMD measurements in men with osteoporosis and controls are summarized in Table 1 . Although there was no statistically significant difference in body mass index (BMI), age, or height between the 2 groups, weight and BMD measurements were significantly lower in the osteoporotic men than in the controls. Plasma 1,25(OH) 2 D 3 concentra- tions were determined in a randomly selected subgroup (n ϭ 50) of male controls. The age, height, weight, BMI, BMD, and DBP and total vitamin D concentrations in these individuals were similar to those in the total control group ( Table 2) . The mean (SD) plasma DBP concentration was significantly higher (P Ͻ0 (21); range, 34 -114] did not differ significantly. Thus, the mean estimated glomerular filtration rates for both groups were in the range thought to be consistent with mild renal impairment. However, none of the control group or patients with osteoporosis had an estimated glomerular filtration rate Ͻ30 mL ⅐ min
, which is regarded as consistent with severe renal impairment.
Discussion
The mean total 25⌷⌯D 3 concentrations for both osteoporotic men and controls in our study were below the concentration that is generally regarded as sufficient (50 nmol/L). Although we found no significant differences in plasma total 25⌷⌯D 3 and 1,25(OH) 2 D 3 between osteoporotic men and controls, the calculated free plasma 25⌷⌯D 3 a Comparison of the 2 groups revealed no significant differences. Fig. 1 . Plasma DBP concentrations in male controls (E; n ϭ 114) and men with osteoporosis (F; n ϭ 56).
The DBP concentrations were significantly higher in osteoporotic men than in male controls (P Ͻ0.0001). The horizontal lines represent 1 SD from the mean value.
(r Յ0.138). There was nevertheless a significant positive correlation between free plasma 25OHD 3 and free 1,25(OH) 2 D 3 (r ϭ 0.614; P Ͻ0.01). These findings suggest that total circulating concentrations of 25⌷⌯D 3 or 1,25(OH) 2 D 3 , although providing information about gross excess and deficiency of the hormone, do not provide information about the physiologically relevant portion of the hormone. The consequences of excessive DBP expression and plasma concentrations have never been addressed.
The existence of vitamin D deficiency despite the presence of total circulating concentrations of 25⌷⌯D 3 or 1,25(OH) 2 D 3 within reference values needs to be established by further investigations, including estimations of parathyroid hormone concentrations. The total mean serum alkaline phosphatase concentration in men with osteoporosis was within the reference interval; therefore, the gross sign of vitamin D deficiency, leading to secondary hyperparathyroidism and consequent increases in alkaline phosphatase, was not evident. Calculated creatinine clearance showed that mild renal impairment of almost similar extent and frequency affected both groups, but none of the men had any evidence of severe renal impairment.
Several studies have demonstrated that the free forms of vitamin D metabolites are more accessible to target cells and therefore produce a higher biological response in vitro and in vivo (20 -22 ) . For example, DBP-null mice fed a vitamin D-replete diet showed no biochemical or histologic evidence of secondary hyperparathyroidism, despite low total plasma concentrations of 25⌷⌯D 3 and 1,25(OH) 2 D 3 (23 ) . This observation supports the "free hormone hypothesis" of simple diffusion of the unbound sterol through the plasma membrane into the target cell. (A), controls; n ϭ 114; patients, n ϭ 56; (B), controls, n ϭ 48; patients, n ϭ 55. There were no significant differences between osteoporotic men and male controls. The horizontal lines represent 1 SD from the mean value. (A), controls; n ϭ 114; patients, n ϭ 56; (B), controls, n ϭ 48; patients, n ϭ 55. The concentrations of both 25OHD 3 (A) and 1,25(OH) 2 D 3 (B) were significantly lower in osteoporotic men than in male controls (P Ͻ0.0001). The horizontal lines represent 1 SD from the mean value.
Clinical Chemistry 52, No. 2, 2006 Furthermore, the extent of inhibition of lymphocyte proliferation and stimulation of 24-hydroxylase in keratinocytes and monocytes by 1,25(OH) 2 D 3 correlates with the free rather than the total concentration of the metabolite (24 ) .
The hypothesis that DBP may buffer free vitamin D metabolites and therefore guard against vitamin D intoxication (24 ) has been challenged by the observation that DBP-null mice are less susceptible to hypercalcemia and its toxic effects than are normal mice (23 ) . A likely explanation for this finding is that DBP and DBP-bound vitamin D metabolites filtered through the glomerulus are reabsorbed by the endocytic receptor megalin into cells in the proximal tubules (25 ) . Megalin-null mice have high urinary excretion of 25OHD 3 and DBP, severe vitamin D deficiency, and bone disease (24 ) , but the contribution of megalin-mediated endocytosis in the extrarenal cellular uptake of 1,25(OH) 2 D 3 from circulating 1,25(OH) 2 D 3 -DBP is unclear.
Albumin and lipoproteins also serve as important carriers for vitamin D metabolites but have lower affinities than DBP. In the 2 groups of men in this study, albumin and lipoprotein concentrations were similar, with very little variation among individuals or between the 2 groups. Albumin binds a relatively small proportion (Ͻ10%) of total blood 25⌷⌯D 3 and 1,25(OH) 2 D 3 , whereas DBP binds ϳ90% of 25⌷⌯D 3 and 1,25(OH) 2 D 3 (16 ) . Furthermore, circulating plasma DBP concentrations in osteoporotic men were significantly different from those in male controls, and we observed considerable variation between individuals. Thus, the plasma DBP concentration, rather than albumin concentration, is likely to have a more substantial effect on the biologically activity of 25OHD 3 and 1,25(OH) 2 D 3 . The ratio of total vitamin D metabolites to plasma DBP may provide a useful index of the biological activity of the vitamin. In view of the relatively low K a ALB values for both 25OHD 3 and 1,25(OH) 2 D 3, it follows that:
Because K a DBP [DBP] is much greater than 1 and K a DBP constant [F] Ϸ [T]/[DBP], this suggests that the ratio of total vitamin D metabolites to plasma DBP may provide a useful index of the biological activity of the vitamin. Therefore, the conclusions of the study would be unaltered if, instead of the calculated free vitamin D metabolites, only the ratio of the respective metabolite to plasma DBP had been used.
The current assays for measuring free 25OHD 3 and 1,25(OH) 2 D 3 are technically demanding and time-consuming and not amenable to routine laboratory use; this is primarily attributable to the extreme hydrophobicity of 25OHD 3 and 1,25(OH) 2 D 3 (26, 27 ) . However, in view of the increasing evidence for the importance of vitamin D deficiency as an etiologic factor in a variety of diseases (1, 2, 4 -7 ) , there is a strong case for establishing a suitable method that can provide information about free (i.e., biologically active) 25OHD 3 and 1,25(OH) 2 D 3 . The above considerations suggest that the measurement of total blood 25OHD 3 and 1,25(OH) 2 D 3 provides a gross index of the vitamin status but that more subtle and borderline cases of apparent vitamin deficiency may be missed. A more suitable method for the routine clinical assessment of these metabolites is therefore required.
We found higher DBP concentrations in men with osteoporosis than the male controls, which led to lower calculated free vitamin D metabolite concentrations. There are 2 possible explanations for this observation: an alteration in liver function or altered gene expression. Indeed, in a previous case-control study, we showed significantly higher concentrations of SHBG in men with symptomatic vertebral fractures compared with agematched male controls (28 ) . Another explanation for the increased DBP concentrations in men with osteoporosis may be altered gene expression, e.g., attributable to a DBP gene polymorphism (15 ) .
